Anti-Inflammation and Anti-Oxidation: The Key to Unlocking the Cardiovascular Potential of SGLT2 Inhibitors and GLP1 Receptor Agonists
Antioxidants · 20.12.2023 · 13 (1) · 16
DOI: 10.3390/antiox13010016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 20.12.2023. Verfasst von Veronika A Myasoedova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union - Next Generation EU - NRRP M6C2 - Investment 2.1 Enhancement and strengthening of biomedical research in the NHS, Italian Ministry of Health, Fondazone Gigi & Pupa Ferrari ONLUS.
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) is a prevalent and complex metabolic disorder associated with various complications, including cardiovascular diseases. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP1-RA) have emerged as novel therapeutic agents for T2DM, primarily aiming to reduce blood glucose levels. However, recent investigations have unveiled their multifaceted effects, extending beyond their glucose-lowering effect. SGLT2i operate by inhibiting the SGLT2 receptor in the kidneys, facilitating the excretion of glucose through urine, leading to reduced blood glucose levels, while GLP1-RA mimic the action of the GLP1 hormone, stimulating glucose-dependent insulin secretion from pancreatic islets. Both SGLT2i and GLP1-RA have shown remarkable benefits in reducing major cardiovascular events in patients with and without T2DM. This comprehensive review explores the expanding horizons of SGLT2i and GLP1-RA in improving cardiovascular health. It delves into the latest research, highlighting the effects of these drugs on heart physiology and metabolism. By elucidating their diverse mechanisms of action and emerging evidence, this review aims to recapitulate the potential of SGLT2i and GLP1-RA as therapeutic options for cardiovascular health beyond their traditional role in managing T2DM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.
- Department of Medicine, Surgery and Dentistry, University of Salerno, 84084 Fisciano, Italy.
- Department of Translational Medical Sciences, Federico II University, 80138 Naples, Italy.
ORCID-Profile: Veronika A Myasoedova, Donato Moschetta, Michele Ciccarelli, Paolo Poggio
Förderung
- European Union - Next Generation EU - NRRP M6C2 - Investment 2.1 Enhancement and strengthening of biomedical research in the NHS
- Italian Ministry of Health
- Fondazone Gigi & Pupa Ferrari ONLUS
- European Union—Next Generation EU—NRRP M6C2—Investment 2.1 Enhancement and strengthening of biomedical research in the NHS
- Fondazone Gigi & Pupa Ferrari ONLUS
Zitieren
APA
Myasoedova, V. A., Bozzi, M., Valerio, V., Moschetta, D., Massaiu, I., Rusconi, V., Di Napoli, D., Ciccarelli, M., Parisi, V., Agostoni, P., Genovese, S., & Poggio, P. (2023). Anti-Inflammation and Anti-Oxidation: The Key to Unlocking the Cardiovascular Potential of SGLT2 Inhibitors and GLP1 Receptor Agonists. Antioxidants, 13(1), 16. https://doi.org/10.3390/antiox13010016
Vancouver
Myasoedova VA, Bozzi M, Valerio V, Moschetta D, Massaiu I, Rusconi V, et al. Anti-Inflammation and Anti-Oxidation: The Key to Unlocking the Cardiovascular Potential of SGLT2 Inhibitors and GLP1 Receptor Agonists. Antioxidants. 2023;13(1):16. doi:10.3390/antiox13010016
BibTeX
@article{Myasoedova2023,
author = {Myasoedova, Veronika A and Bozzi, Michele and Valerio, Vincenza and Moschetta, Donato and Massaiu, Ilaria and Rusconi, Valentina and Di Napoli, Daniele and Ciccarelli, Michele and Parisi, Valentina and Agostoni, Piergiuseppe and Genovese, Stefano and Poggio, Paolo},
title = {Anti-Inflammation and Anti-Oxidation: The Key to Unlocking the Cardiovascular Potential of SGLT2 Inhibitors and GLP1 Receptor Agonists},
journal = {Antioxidants},
year = {2023},
volume = {13},
number = {1},
pages = {16},
doi = {10.3390/antiox13010016}
}
EUVIMED